Dolby Laboratories Stock Today

DLB Stock  USD 81.98  11.07  15.61%   

Performance

8 of 100

 
Weak
 
Strong
OK

Odds Of Distress

Less than 8

 
High
 
Low
Low
Dolby Laboratories is trading at 81.98 as of the 21st of November 2024, a 15.61 percent up since the beginning of the trading day. The stock's open price was 70.91. Dolby Laboratories has only a 8 % chance of going through financial distress over the next few years but had a somewhat ok performance during the last 90 days. Equity ratings for Dolby Laboratories are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 2nd of December 2022 and ending today, the 21st of November 2024. Click here to learn more.
Business Domain
Technology Hardware & Equipment
IPO Date
17th of February 2005
Category
Industrials
Classification
Information Technology
Dolby Laboratories, Inc. creates audio and imaging technologies that transform entertainment and communications at the cinema, DTV, transmissions and devices, mobile devices, OTT video and music services, and home entertainment devices. Dolby Laboratories, Inc. The company has 59.68 M outstanding shares of which 887.73 K shares are currently shorted by investors with about 3.21 days to cover. More on Dolby Laboratories

Moving against Dolby Stock

  0.39WBX Wallbox NVPairCorr

Dolby Stock Highlights

ESG Sustainability
Environmental
Governance
Social
CEOKevin Yeaman
Old NameMulti Units France - Lyxor UCITS ETF Daily Leveraged Bund
Business ConcentrationElectronic Equipment, Instruments & Components, Technology Hardware & Equipment, Information Technology, NYSE Composite, SP Midcap 400, Information Technology, Electronic Equipment, Instruments & Components, Information Technology Services, Technology (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Return On Assets0.06840.116
Way Down
Slightly volatile
Asset Turnover0.470.4096
Fairly Up
Pretty Stable
Gross Profit Margin0.890.8897
Slightly Up
Pretty Stable
Total Current Liabilities228.7 M417.8 M
Way Down
Slightly volatile
Non Current Liabilities Total115.7 M225.9 M
Way Down
Slightly volatile
Total AssetsB3.1 B
Way Down
Slightly volatile
Total Current AssetsB1.2 B
Fairly Down
Slightly volatile
Total Cash From Operating Activities314 M327.3 M
Sufficiently Down
Slightly volatile
Debt Levels
Dolby Laboratories can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Dolby Laboratories' financial leverage. It provides some insight into what part of Dolby Laboratories' total assets is financed by creditors.
Liquidity
Dolby Laboratories has 46.99 M in debt with debt to equity (D/E) ratio of 0.02, which may show that the company is not taking advantage of profits from borrowing. Dolby Laboratories has a current ratio of 5.16, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Note however, debt could still be an excellent tool for Dolby to invest in growth at high rates of return.

Sale Purchase Of Stock

(209.03 Million)
Dolby Laboratories (DLB) is traded on New York Stock Exchange in USA. It is located in 1275 Market Street, San Francisco, CA, United States, 94103-1410 and employs 2,246 people. Dolby Laboratories is listed under Electronic Equipment, Instruments & Components category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a total capitalization of 6.76 B. Dolby Laboratories runs under Electronic Equipment, Instruments & Components sector within Information Technology industry. The entity has 59.68 M outstanding shares of which 887.73 K shares are currently shorted by investors with about 3.21 days to cover. Dolby Laboratories has about 620.13 M in cash with 327.25 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.4.
Check Dolby Laboratories Probability Of Bankruptcy
Ownership Allocation
Dolby Laboratories holds a total of 59.68 Million outstanding shares. The majority of Dolby Laboratories outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Dolby Laboratories to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Dolby Laboratories. Please pay attention to any change in the institutional holdings of Dolby Laboratories as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Dolby Ownership Details

Dolby Stock Institutional Holders

InstituionRecorded OnShares
Mackenzie Investments2024-09-30
985.8 K
Wells Fargo & Co2024-06-30
977.6 K
Dimensional Fund Advisors, Inc.2024-09-30
870.5 K
Schroder Investment Management Group2024-06-30
763.1 K
Charles Schwab Investment Management Inc2024-09-30
717.6 K
First Trust Advisors L.p.2024-06-30
697.6 K
Norges Bank2024-06-30
633.9 K
Aqr Capital Management Llc2024-06-30
627.2 K
Jpmorgan Chase & Co2024-06-30
616.7 K
Morgan Stanley - Brokerage Accounts2024-06-30
11.7 M
Vanguard Group Inc2024-09-30
M
View Dolby Laboratories Diagnostics

Dolby Laboratories Historical Income Statement

At present, Dolby Laboratories' Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's EBIT is expected to grow to about 248.1 M, whereas Total Revenue is forecasted to decline to about 860.5 M. View More Fundamentals

Dolby Stock Against Markets

Dolby Laboratories Corporate Directors

Avadis TevanianIndependent DirectorProfile
Simon SegarsIndependent DirectorProfile
David DolbyIndependent DirectorProfile
Roger SiboniIndependent DirectorProfile
When determining whether Dolby Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dolby Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dolby Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dolby Laboratories Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dolby Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For information on how to trade Dolby Stock refer to our How to Trade Dolby Stock guide.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Electronic Equipment, Instruments & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dolby Laboratories. If investors know Dolby will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dolby Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.353
Earnings Share
3.11
Revenue Per Share
13.172
Quarterly Revenue Growth
(0.03)
Return On Assets
0.0516
The market value of Dolby Laboratories is measured differently than its book value, which is the value of Dolby that is recorded on the company's balance sheet. Investors also form their own opinion of Dolby Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Dolby Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dolby Laboratories' market value can be influenced by many factors that don't directly affect Dolby Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dolby Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dolby Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dolby Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.